BRIEF-Astrazeneca Enters Collaboration Worth Up To $5.22 Bln With CSPC Pharmaceuticals

Reuters
13 Jun
BRIEF-Astrazeneca Enters Collaboration Worth Up To $5.22 Bln With CSPC Pharmaceuticals

June 13 (Reuters) - AstraZeneca PLC AZN.L:

  • ASTRAZENECA PLC - ASTRAZENECA ENTERS INTO COLLABORATION WITH CSPC

  • ASTRAZENECA PLC - CSPC TO RECEIVE $110 MILLION UPFRONT, UP TO $5.22 BILLION IN MILESTONE PAYMENTS

  • ASTRAZENECA PLC - COLLABORATION TO ADVANCE DISCOVERY OF NOVEL ORAL CANDIDATES

Source text: ID:nRSM6582Ma

Further company coverage: AZN.L

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10